Nurse Practitioner in Villanova, PA Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Amanda Petruskevicius, CRNP Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 800 E Lancaster Ave, Villanova, PA 19085 Phone: 610-519-4500 |
Mrs. Mary Agnes Ostick, CRNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 800 Lancaster Ave, Villavnoa University, Villanova, PA 19085 Phone: 610-519-4070 Fax: 610-519-4047 |
Tierney Brennan, Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 464 Inveraray Rd, Villanova, PA 19085 Phone: 630-640-1167 |
Leeann M. Webb, APN Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Nemours Dupont Pediatrics, Villanova, 789 E. Lancaster Ave., Suite 10, Villanova, PA 19085 Phone: 484-381-4010 Fax: 484-381-4020 |
News Archive
Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL
The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma.
University of Maryland receives grant from NCRR to acquire superconducting NMR spectrometer
The University of Maryland, in partnership with the University of Maryland, Baltimore and University of Maryland Baltimore County, has received a $7.9 million federal grant to acquire a superconducting 950 MHz Nuclear Magnetic Resonance (NMR) magnet that will help researchers unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.
Study determines effectiveness of gabapentin for treatment of vulvodynia in women
A chronic syndrome called vulvodynia that affects from four to seven percent of women is being studied by physicians at The Women's Health Institute at Robert Wood Johnson Medical School, part of Rutgers, The State University of New Jersey, in hopes of alleviating sometimes excruciating pain.
Scancell signs worldwide licensing agreement with NIH for TRP-2 and gp100 melanoma antigens
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
› Verified 9 days ago